News
- Author:
- Nancy A. Melville
Publish date: February 1, 2022
PCV15 and PREVNAR20 received approval from the FDA in July 2021, providing an impetus for the revised recommendations.
News
- Author:
- Nancy A. Melville
Publish date: February 1, 2022
“This is not dissimilar to research with many other nutrients showing that increasing intake above the adequate intake has no further health b...
News
- Author:
- Nancy A. Melville
Publish date: January 26, 2022
Proactive therapeutic drug monitoring over 1 year significantly improves disease control in infliximab treatment of IBDs.
News
- Author:
- Nancy A. Melville
Publish date: January 24, 2022
Probiotic treatment given alongside chemotherapy is sufficient to protect against memory disturbances in patients with breast cancer.
News
- Author:
- Nancy A. Melville
Publish date: January 13, 2022
The procedure can be performed on an outpatient basis in approximately 20 minutes.
News
- Author:
- Nancy A. Melville
Publish date: January 6, 2022
New research further supports the inclusion of people with HIV in transplant resource allocation.
News
- Author:
- Nancy A. Melville
Publish date: January 4, 2022
The findings “underscore the fact that the desensitization achieved with peanut oral immunotherapy is a transient immune state.”
News
- Author:
- Nancy A. Melville
Publish date: December 28, 2021
“To our knowledge, this analysis presents the first and largest investigation of vaccination rates among people w...
News
- Author:
- Nancy A. Melville
Publish date: December 17, 2021
“This will save tens of thousands of women the time, expense, and potentially harmful side effects that can be associated with chemotherapy infusio...
News
- Author:
- Nancy A. Melville
Publish date: December 17, 2021
Only 25%-30% of adults in the U.S. are reported to be currently vaccinated for hepatitis B, even though safe and highly effective vaccines are avai...
News
- Author:
- Nancy A. Melville
Publish date: December 15, 2021
The number of CDC-funded HIV tests declined by more than 1 million in 2020 amid the COVID-19 restrictions.
News
- Author:
- Nancy A. Melville
Publish date: December 15, 2021
People with HIV are known to be at an increased risk of diabetes and the long-term complications of the disease.
News
- Author:
- Nancy A. Melville
Publish date: December 8, 2021
Adding ibrutinib to standard chemotherapy improves DLBCL survival in younger patients, especially among certain genetic subtypes.
News
- Author:
- Nancy A. Melville
Publish date: December 8, 2021
Compared with nonthyroid cancer patients, those receiving thyroidectomy for thyroid cancer show up to a 40% greater risk for diabetes.
News
- Author:
- Nancy A. Melville
Publish date: December 7, 2021
New data suggest benefits of drug monitoring to assess risks for pancreatitis and other toxicities.
